Allscripts said it is buying Eclipsys in an all-stock deal that will take out its British investors, Misys.
The acquisition will value each share of Atlanta-based Eclipsys at 1.2 Allscripts shares — meaning a 19 percent premium on the basis of yesterday’s closing prices in Nasdaq composite trading. Misys Plc, the U.K. company that owns 54.6 percent of Chicago-based Allscripts, must sell much of its stake to facilitate the transaction, Misys said in a statement today.
Eclipsys, which is based in Atlanta, is best known for a hospital computing system called Sunrise emphasizing physician order entry. Allscripts, in turn, is best known for a SaaS offering used by medical offices.
Allscripts fell $1.77, or 9.6 percent, to $16.65 at 10:56 a.m. New York time in Nasdaq Stock Market composite trading. Eclipsys rose 13 cents to $18.64.
The combined company will have plays in both hospital and medical office IT, but it will still have to answer hard questions from customers. Like when will their stuff really work together, and are you getting distracted, and when will I get my sweet, sweet stimulus cash.